The European Investment Bank (EIB) will advise Antibiotice , one of Romania’s largest pharmaceutical companies, on strengthening its corporate governance framework in order to support the company’s future growth. Under a new advisory services agreement, the EIB will work with Antibiotice to align its risk management framework and business operations with international best practices in the pharmaceutical sector. The advisory agreement follows a request from Antibiotice aimed at strengthening

Tag-uri: Medicamente